miDiagnostics
Series D in 2024
miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.
Lizy operates a digital car leasing platform for small and medium-sized enterprises and professionals. The service enables online leasing with transparent all-in pricing, flexible contract terms, and a selection of high-quality used cars that are immediately available. Customers can order a vehicle online and have it delivered to their location, simplifying the leasing process and reducing hassle and cost. Based in Brussels, Belgium, Lizy focuses on delivering quick and easy access to leased vehicles through its online platform.
Itineris
Venture Round in 2022
Itineris develops and implements UMAX, a cloud-based CIS and CRM platform for utilities that uses workflow automation and AI to manage meter-to-cash processes, revenue collection, assets, rates, conservation, marketing, and campaigns, while improving customer engagement and operational efficiency. The platform is built on Microsoft Dynamics 365 and delivered as a service in the Azure cloud, helping water and energy utilities align IT systems with business processes and address regulatory, infrastructural, and operational challenges. Founded in 2003, Itineris has implemented solutions for utilities in Europe and the United States, including De Watergroep, Eneco, SSE, Flogas, and public sector clients such as the New York Department of Environmental Protection and the Boston Water and Sewer Commission.
SOPHiA GENETICS
Series E in 2019
SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDMâ„¢ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.
SOPHiA GENETICS
Series D in 2017
SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDMâ„¢ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.